Jennifer Jarrett
CIK 1671311 · Director, President and CEO · last filed 2026-09-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
RCUS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
525 MARKET ST., 36TH FLOOR
SAN FRANCISCO, CA 94105
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DMRA | Director, President and CEO | 512,500 | $21.17 | $10.85M | $252.9K | 2 | 2026-09-28 |
| ZURA | Director | — | $3.66 | — | $0 | 3 | 2026-06-22 |
| SGMT | Director | — | $9.82 | — | $0 | 3 | 2026-06-15 |
| SNDX | Director | 114,000 | $13.67 | $1.56M | $0 | 9 | 2026-02-06 |
| RCUS | Chief Operating Officer | 224,024 | $17.70 | $3.97M | -$11.77M | 39 | 2026-01-26 |
| Zura Bio Ltd (ZURAW) Delisted | Director | — | $1.08 | — | $0 | 1 | 2023-05-22 |
| Radius Health, Inc. (RDUS) Delisted | Director | — | $30.00 | — | $0 | 2 | 2022-08-15 |
| ARENA PHARMACEUTICALS INC (ARNA) Delisted | Director | 3,067 | $99.99 | $306.7K | $0 | 6 | 2022-03-11 |
| Surrozen, Inc./DE (SRZNW) Delisted | 30,000 | $0.00 | $45 | $0 | 1 | 2021-08-13 | |
| BOLD | Director | — | $2.41 | — | $0 | 5 | 2020-01-15 |
| MEDIVATION, INC. (MDVN) Delisted | Chief Financial Officer | 29,971 | — | — | $0 | 1 | 2016-04-08 |
Recent Filings · Page 6 of 9
86 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-08-15 | Radius Health, Inc. (RDUS) Delisted | Disp (D) | — | $0 | EDGAR |
| 2022-06-21 | RCUS | Sell (S) | −12,695 | -$272.3K | EDGAR |
| 2022-05-20 | Radius Health, Inc. (RDUS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-18 | RCUS | Sell (S) | −9,617 | -$304.1K | EDGAR |
| 2022-03-11 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Mixed | −11,217 | $0 | EDGAR |
| 2022-03-10 | RCUS | Grant (A) | +31,250 | $0 | EDGAR |
| 2022-02-03 | SNDX | Grant (A) | +16,000 | $0 | EDGAR |
| 2021-12-22 | RCUS | Sell (S) | −34,822 | -$1.44M | EDGAR |
| 2021-12-20 | RCUS | Sell (S) | −12,678 | -$508.7K | EDGAR |
| 2021-09-22 | RCUS | Sell (S) | −47,500 | -$1.68M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.